COMPARATIVE IN-VITRO STUDIES ON THE BETA-LACTAMASE-INHIBITING EFFECT OF CLAVULANIC ACID AND SULBACTAM ON AMPICILLIN-RESISTANT ENTEROBACTERIACEAE (REPRINTED FROM ARZNEIM FORSCH, VOL 37, PG 1116, 1987)
H. Grimm, COMPARATIVE IN-VITRO STUDIES ON THE BETA-LACTAMASE-INHIBITING EFFECT OF CLAVULANIC ACID AND SULBACTAM ON AMPICILLIN-RESISTANT ENTEROBACTERIACEAE (REPRINTED FROM ARZNEIM FORSCH, VOL 37, PG 1116, 1987), International journal of antimicrobial agents, 6, 1996, pp. 9-14
Clavulanic acid and sulbactam alone are ineffective against Pseudomona
s and enterococci. Staphylococci and Enterobacteriaceae are inhibited
by high concentrations not attainable under clinical conditions. Strai
ns of Acinetobacter, especially A. lwoffii are susceptible to clavulan
ic acid and highly susceptible to sulbactam. The ampicillin/sulbactam
combination is superior to ampicillin/ clavulanic acid against Citroba
cter freundii, Enterobacter spp. and Morganella morganii. The latter c
ombination is superior against Klebsiella spp. and Escherichia coli. A
ntagonistic effects are more frequent with the clavulanic acid combina
tion (Enterobacter spp. and C. freundii) but are rarely observed with
the sulbactam combination (Providencia spp, and P. rettgeri).